Does allopurinol (a xanthine oxidase inhibitor) have clinically useful anti-ischaemic effects in angina pectoris? - A randomised, double-blind, placebo-controlled trial

Registry ID

EUCTR2006-004611-21

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

University of Dundee

Start date

2008-12-29

Completion date

2008-09-05

Last update

2026-08-16

Conditions

• Angina Pectoris

Summary

The main objective is to investigate if allopurinol (a xanthine oxidase inhibitor) has a clinically useful anti-ischaemic effects in patients with angina pectoris. This will primarily be assessed by the exercise treadmill test using a standard full Bruce protocoal. Patients will also be asked to record the number of angina attacks per week and their GTN consumption.

Locations

• , , UK

Related clinical trials

• Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
• Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)
• Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions
• Diagnostic Performance of Artificial Intelligence Algorithms in Prediction of Acute Coronary Syndrome Based on White Blood Cell Properties
• Echocardiography: Value and Accuracy at REst and STress
• Personalized Evaluation of Susptected Myocardial Ischemia

View on source registry